Capnia to Present at Upcoming Investor Conferences
September 06 2016 - 6:00AM
Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that
develops and commercializes innovative diagnostics, devices and
therapeutics addressing unmet medical needs, today announced that
Anish Bhatnagar, M.D., Chief Executive Officer, will present at two
upcoming investor conferences:
- The Rodman & Renshaw 18th Annual Global Investment
Conference on Monday, September 12, 2016 at 12:05 PM ET at the
Lotte New York Palace Hotel.
- The 2016 Aegis Capital Growth Conference on Wednesday,
September 21, 2016 at 11:00 AM PT at the Wynn Las Vegas.
The presentations will be webcast live and may
be accessed by visiting the “Events & Presentations” section of
the Company's website at www.capnia.com. The webcasts will also be
available on the Company’s website for a limited period of time
following the conferences.
About Capnia
Capnia is a leading provider and developer of
innovative healthcare products used for the screening, detection
and treatment of medical conditions. Capnia’s flagship products,
Serenz® Allergy Relief and CoSense® ETCO Monitor, are based on its
proprietary technologies, which utilize precision metering of gas
flow. Capnia currently markets Serenz Allergy Relief in the
UK and Ireland. The CoSense ETCO Monitor, which measures end-tidal
carbon monoxide (ETCO) that can be used to detect hemolysis, and
the Infant Solutions product line, including innovative pulmonary
resuscitation devices for neonates and infants, are marketed
globally. Capnia is also clinically evaluating its nasal,
non-inhaled CO2 technology to treat trigeminally-mediated pain
conditions such as cluster headache and trigeminal neuralgia.
For more information, please visit www.capnia.com.
Investor Relations Contact:
Michelle Carroll/Susie Kim
Argot Partners
(212) 600-1902
michelle@argotpartners.com
susan@argotpartners.com
Soleno Therapeutics (NASDAQ:SLNO)
Historical Stock Chart
From Apr 2024 to May 2024
Soleno Therapeutics (NASDAQ:SLNO)
Historical Stock Chart
From May 2023 to May 2024